Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms.

  title={Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms.},
  author={Francesco Panza and Vincenza Frisardi and Cristiano Capurso and Bruno Pietro Imbimbo and Gianluigi Vendemiale and Andrea Santamato and Grazia D’Onofrio and Davide Seripa and Daniele Sancarlo and Alberto Pilotto and Vincenzo Solfrizzi},
  journal={Journal of Alzheimer's disease : JAD},
  volume={21 3},
A possible role of vascular and lifestyle-related factors was recently proposed for age-related changes of cognitive function, predementia syndromes, and cognitive decline of degenerative (Alzheimer's disease, AD) or vascular origin (vascular dementia, VaD). At present, cumulative evidence suggests that vascular risk factors may be important in the development of mild cognitive impairment (MCI), dementia, and AD. Among vascular-related factors, metabolic syndrome (MetS) has been associated with… 

Figures from this paper

Metabolic syndrome, mild cognitive impairment, and dementia.

Future research aimed at identifying mechanisms that underlie comorbid associations will not only provide important insights into the causes and interdependencies of predementia and dementia syndromes, but will also inspire novel strategies for treating and preventing these disorders.

Current epidemiological approaches to the metabolic-cognitive syndrome.

The MCS model could help to explain the complex relationship between metabolic disorders and cognitive disturbances and the boundaries between normal and pathological conditions, with a better understanding of clinical and neuropathological features of these metabolic-based cognitive disorders.

Metabolic Syndrome as a Risk Factor for Alzheimer's Disease: Is Aβ a Crucial Factor in Both Pathologies?

It could be argued that Aβ could be a convergent factor in the development of both pathologies, as well as insulin receptor signaling, which is involved in tau phosphorylation and amyloid β (Aβ) metabolism.


To the Editor: An increasing body of evidence supports a possible role of serum and plasma lipids in promoting the pathological processes that lead to Alzheimer’s disease (AD) and other dementia

Association Between Cognitive Function and Clustered Cardiovascular Risk of Metabolic Syndrome in Older Adults at Risk of Cognitive Decline

Combined risk due to multiple risk factors in MetS was related to lower global cognitive performance and executive function, which may point to opportunities for cognitive testing in older adults as individuals may experience cognitive changes.

Metabolic Syndrome and Amyloid Accumulation in the Aging Brain.

Metabolic syndrome was associated with accelerated Aβ accumulation in PiB+ individuals and may be an important factor in the progression of AD pathology.

A review of the major vascular risk factors related to Alzheimer's disease.

The present review is dedicated to the epidemiology of vascular risk factors proven to play a role in facilitating onset and progression of cognitive impairment. These include hypertension,



Vascular risk factors, alcohol intake, and cognitive decline

C cumulative evidence suggested that vascular risk factors may be important in the development of mild cognitive impairment, dementia, and AD, and vascular risk factor management, lifestyle changes, and drugs could be employed together to delay the onset of dementia syndromes.

Lifestyle-related factors in predementia and dementia syndromes

Results are awaited from large multicenter randomized clinical trials in older persons that may clarify the possible synergy, for example, between moderate exercise, physical activity and healthy Mediterranean diet on cognition in the elderly.

The metabolic syndrome and development of cognitive impairment among older women.

An association between the metabolic syndrome and the number of components and risk of developing cognitive impairment in older women is found and additional studies are needed to determine if screening and close management of at-risk elderly women would diminish the incidence of cognitive impairment.

Vascular risk factors, cognitve decline, and dementia

Vascular risk factors and their treatments are a promising avenue of research for prevention of dementia, and further long-term, placebo-controlled, randomized studies, need to be performed.

The metabolic syndrome, inflammation, and risk of cognitive decline.

Findings support the hypothesis that the metabolic syndrome contributes to cognitive impairment in elders, but primarily in those with high level of inflammation.

Metabolic Syndrome and Alzheimer's Disease: A Link to a Vascular Hypothesis?

Accumulating evidence suggests a “vascular hypothesis” to be related to the pathology of Alzheimer's disease and lifestyle interventions toward an early and effective cardiovascular risk-factor management to reduce the cardiometabolic and the cognitive decline risk.

Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging

Cardiovascular risk factors and cognitive function

The metabolic syndrome is associated with decelerated cognitive decline in the oldest old

The association between the metabolic syndrome and accelerated cognitive decline, which has been reported in persons up to age 75, is not evident in a population of the oldest old, suggesting the concept of the metabolic Syndrome may be less valid in this age group.

Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?

The role of these factors in the development of cognitive decline and dementia, including underlying mechanisms that influence amyloid-beta peptide metabolism and tau protein hyperphosphorylation, the principal neuropathological hallmarks of AD are discussed.